Investor Presentaiton
Q3FY24 SNAPSHOT
Hospital business revenues grew by 9.6% to INR 1,389.5 Cr versus
INR 1,267.4 Cr in Q3FY23. For 9MFY24, revenue grew by 11.7% YoY to
INR 4,196.2 Cr.
Hospital Business Operating EBITDA stood at INR 250.8 Cr, up 18.8%; Operating
margin increased to 18.0% in Q3FY24 from 16.7% in Q3FY23.
Q3FY24 hospital business ARPOB was at INR 2.23 Cr p.a. vs INR 2.02 Cr p.a. in
Q3FY23, up 10.6%
Occupancy for the quarter stood at 64.0% versus 66.1% in Q3FY23
➤ The company's diagnostics business reported gross revenues of INR 330.7 Cr
versus INR 331.5 Cr in Q3FY23*. For 9MFY24*, revenue grew by 1.8% to
INR 1,033.6 Cr.
Net debt to EBITDA stood at 0.45x versus 0.41x in the corresponding previous
period; net debt stands at INR 518 Cr
In Feb 24, as part of the company's ongoing portfolio rationalization strategy,
Fortis divested its Malar, Chennai facility
*As per the segmental reporting in accordance with Ind AS 108, as provided in the statement of unaudited
consolidated financial results for the quarter and nine months ended December 31, 2023
it Fortis
9View entire presentation